US2016353721A1PendingUtilityA1

Sperm-Specific Cation Channel, Catsper3, and Uses Therefor

Assignee: CHILDREN'S MEDICAL CENTER CORPPriority: Aug 7, 2002Filed: Aug 19, 2016Published: Dec 8, 2016
Est. expiryAug 7, 2022(expired)· nominal 20-yr term from priority
A01K 2217/072C07K 14/705C12Q 1/6883C12Q 1/025G01N 33/5044C12Q 2600/156A01K 67/0278G01N 33/5014A01K 2217/05A61K 38/00A01K 2227/105
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A transgenic non-human animal comprising a modification into the non-human animal, the modification comprising an insertion of a nucleic acid encoding a CatSper3 protein, the CatSper3 protein comprising at least 90% similarity to the amino acid sequence of SEQ ID NO: 4, and wherein the CatSper3 protein has CatSper3 activity. 
     
     
         2 . A transgenic non-human animal comprising a modification into the non-human animal, wherein the modification is replacement of an endogenous CatSper3 protein sequence with a reporter or marker gene, wherein the CatSper3 protein comprises at least 90% similarity to the amino acid sequence of SEQ ID NO: 4. 
     
     
         3 . A transgenic non-human animal comprising a modification into the non-human animal, the modification comprising inactivation of an endogenous CatSper3 protein, wherein the CatSper3 protein comprises at least 90% similarity to the amino acid sequence of SEQ ID NO: 4. 
     
     
         4 . The transgenic non-human animal of  claim 1 , wherein the modification is by homologous recombination to result in expression of the reporter gene. 
     
     
         5 . The transgenic non-human animal of  claim 1 , wherein the modification is by homologous recombination to result in expression of the marker gene. 
     
     
         6 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the CatSper3 sequences are conspecific to the transgenic animal. 
     
     
         7 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the CatSper3 sequences are transpecific to the transgenic animal. 
     
     
         8 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the animal is a mouse, rat, hamster, guinea pig, rabbit, dog, cat, goat, sheep, pigs, or a non-human primate. 
     
     
         9 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the animal is a mouse. 
     
     
         10 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the animal is a non-human primate.

Join the waitlist — get patent alerts

Track US2016353721A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.